Veterans affairs seamless phase II/III randomized trial of standard systemic therapy with or without PET-directed local therapy for oligorecurrent prostate cancer (VA STARPORT).
Year: 2022
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Abhishek A Solanki, Christopher A Schroth, Caitlin Authier, Kimberly Carlson, Isla Garraway, Tamara Haegerich, Elizabeth Henry, Jeffrey A Jones, Remya Joseph, Thomas Koppes, Drew Moghanaki, Marcus Lee Quek, Matthew Rettig, Tammy Rhoda, Timothy Ritter, Lisa Robin, Joseph Kamel Salama, Elinore Zacny, Nicholas George Nickols
Institutions: Loyola University Chicago, Edward Hines, Jr. VA Hospital, VA Greater Los Angeles Healthcare System, Loyola University Medical Center, Atlanta VA Health Care System, Atlanta VA Medical Center, University of California, Los Angeles, VA West Los Angeles Medical Center, UCLA Jonsson Comprehensive Cancer Center, Durham VA Health Care System, Durham VA Medical Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4286294600